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The multiprotein Mediator complex is a coactivator re-
quired for activation of RNA polymerase II transcription
by DNA bound transcription factors. We previously iden-
tified and partially purified a mammalian Mediator com-
plex from rat liver nuclei (Brower, C.S., Sato, S., Tomo-
mori-Sato, C., Kamura, T., Pause, A., Stearman, R.,
Klausner, R.D., Malik, S., Lane, W.S., Sorokina, I., Roeder,
R.G., Conaway, J.W., and Conaway, R.C. (2002) Proc. Natl.
Acad. Sci. U. S. A. 99, 10353–10358). Analysis by tandem
mass spectrometry of proteins present in the most highly
purified rat Mediator fractions led to the identification of
a collection of new mammalian Mediator subunits, as well
as several potential Mediator subunits including a previ-
ously uncharacterized protein encoded by the FLJ10193
open reading frame. In this study, we present direct bio-
chemical evidence that the FLJ10193 protein, which we
designate Med25, is a bona fide subunit of the mammalian
Mediator complex. In addition, we present evidence that
Med25 shares structural and functional properties with
Saccharomyces cerevisiae Mediator subunit Cse2 and may
be a mammalian Cse2 ortholog. Taken together, our find-
ings identify a novel mammalian Mediator subunit and
shed new light on the architecture of the mammalian
Mediator complex.
The Mediator (Med)1 is a multiprotein coactivator that pro-
motes RNA polymerase II transcriptional activation through
direct interactions with transcription factors bound at enhanc-
ers and upstream promoter elements and with polymerase and
the general initiation factors at the core promoter. The Medi-
ator was first identified in Saccharomyces cerevisiae and found
to be comprised of more than twenty proteins including Srb2,
Srb4, Srb5, Srb6 Srb7, Srb8, Srb9, Srb10, Srb11, Med1, Med2,
Med4, Med6, Med7, Med8, Med11, Pgd1, Rox3, Cse2, Nut1,
Nut2, Gal11, Sin4, and Rgr1 (1).
A mammalian Mediator complex similar to yeast Mediator
was subsequently identified in several laboratories and desig-
nated mouse Mediator (2), TRAP (thyroid hormone receptor-
associated proteins)/SMCC (Srb-Med-containing cofactor) (3),
ARC (activator-recruited cofactor) (4), DRIP (vitamin D recep-
tor-interacting proteins) (5), CRSP (cofactor required for Sp1
activation) (6), or rat Mediator (7, 8). Biochemical character-
ization of the mammalian Mediator complex has revealed that
it is composed of apparent homologs of many of the S. cerevisiae
Mediator subunits including TATA-binding protein related fac-
tor-proximal protein (TRFP) (Srb2), TRAP80 (Srb4), p28b
(Srb5), Surf5 (Srb6), Srb7, TRAP240 (Srb8), TRAP230 (Srb9),
Cdk8 (Srb10), Cyclin C (Srb11), TRAP36 (Med4), Med6, Med7,
Med8, HSPC296 (Med11), LCMR1 (Rox3), Nut2, Sur2 (Gal11),
TRAP95 (Sin4), and Rgr1 (reviewed in Ref. 9).
In a previous study (7), we partially purified a mammalian
Mediator complex from rat liver nuclei. Analysis of proteins
present in our most highly purified rat Mediator fractions by
tandem mass spectrometry led to the identification of a large
fraction of the known mammalian Mediator subunits, as well
as a collection of potentially new Mediator subunits. In this
report, we identify one such protein encoded by the FLJ10193
open reading frame as a new subunit of the mammalian Medi-
ator complex.
EXPERIMENTAL PROCEDURES
Materials—Anti-FLAG (M2) monoclonal antibodies, anti-Myc
(C-3956) rabbit polyclonal antibodies, anti-FLAG (M2) agarose, and
FLAG peptide were purchased from Sigma. Anti-Myc (9E10) mono-
clonal antibodies were obtained from Roche Applied Science. Anti-
TRAP220 (C-19), anti-Cdk8 (D-9), and anti-Med6 (E-20) antibodies were
obtained from Santa Cruz Biotechnology. Anti-Med8 rabbit polyclonal
antibodies were raised against a peptide corresponding to Med8 resi-
dues 247–268 (Cocalico Biologicals, Inc.). Anti-TRAP80, anti-LCMR1,
anti-Intersex, anti-TRAP36, anti-p28b, anti-Surf5, anti-HSPC296, and
anti-Med25 rabbit polyclonal antibodies were raised against recombi-
nant proteins expressed in insect cells or Escherichia coli (Cocalico
Biologicals, Inc.). Light chain-specific anti-mouse antibodies were pur-
chased from Bethyl Laboratories and labeled with Alexa Fluor 680
(Molecular Probes) according to the manufacturer’s instructions. Super-
Signal West Dura extended duration substrate and SuperSignal West
Femto Maximum Sensitivity Substrate were obtained from Pierce. Glu-
tathione-Sepharose 4 Fast Flow and Glutathione-Sepharose 4B beads
were from Amersham Biosciences.
Anti-FLAG Agarose Chromatography—Anti-FLAG agarose immuno-
affinity chromatography was carried out essentially as described for
purification of the TRAPSMCC Mediator complex (10). HeLa cell nu-
clear extracts were prepared according to the method of Dignam et al.
(11). Undialyzed nuclear extracts were incubated with anti-FLAG (M2)
agarose beads in 10 mM Hepes-NaOH (pH 7.9), 1.5 mM MgCl2, 0.3 M
KCl, and 0.2% Triton X-100 for at least 4 h at 4 °C. The beads were
washed 5 times with a 50-fold excess of the same buffer and once with
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a 50-fold excess of 10 mM Hepes-NaOH (pH 7.9), 1.5 mM MgCl2, 0.1 M
NaCl, and 0.05% Triton X-100. Beads were then eluted with 10 mM
Hepes-NaOH (pH 7.9), 1.5 mM MgCl2, 0.1 M NaCl, and 0.05% Triton
X-100, and 0.2 mg/ml FLAG peptide. All buffers contained 1:1000-fold
dilution of Protease Inhibitor Mixture (Sigma catalog number P8340).
Mass Spectrometry—Identification of proteins was accomplished us-
ing a modification of the MudPIT procedure described by Washburn et
al. (12). Aliquots of anti-FLAG agarose eluates were brought to 100 l
with 1 M Tris-HCl (pH 8.5) and H2O to a final concentration of 100 mM
Tris-HCl. Solid urea was added to 8 M. Proteins were reduced with 5 mM
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, Roche), alkylated
with 20 mM iodoacetamide (IAM, Sigma), and digested with endopro-
teinase Lys-C (Roche) for at least 6 h at 37 °C. Proteins were then
diluted 4 times 100 mM Tris-HCl (pH 8.5) and digested overnight at
37 °C with modified Trypsin (Roche) in the presence of 2 mM CaCl2.
Peptide mixtures were pressure-loaded onto a 250 m inner diameter
(i.d.) fused-silica capillary packed first with 4 cm of 5 m strong cation
exchange material (Partisphere SCX, Whatman), followed by 2 cm of 5
m C18 reverse phase particles (Aqua, Phenomenex). Loaded and
washed microcapillaries were connected via a 2 m filtered union
(UpChurch Scientific) to a 100 m i.d. column, which had been pulled to
a 5 m i.d. tip using a P-2000 CO2 laser puller (Sutter Instruments),
then packed with 10 cm of reverse phase particles and equilibrated in
5% acetonitrile, 0.1% formic acid (Buffer A). This split-column was then
installed in-line with a Quaternary Agilent 1100 series HPLC pump.
Overflow tubing was used to decrease the flow rate from 0.1 ml/min to
about 200–300 nl/min. Fully automated 6 step chromatography runs
were carried out. Three different elution buffers were used: Buffer A;
80% acetonitrile, 0.1% formic acid (Buffer B); and 0.5 M ammonium
acetate, 5% acetonitrile, 0.1% formic acid (Buffer C). In such sequences
of chromatographic events, peptides are sequentially eluted from the
SCX resin to the reverse phase resin by increasing salt steps (increase
in Buffer C concentration), followed by organic gradients (increase in
Buffer B concentration). The last chromatography step consists in a
high salt wash with 100% Buffer C followed by the acetonitrile gradient.
The application of a 2.5 kV distal voltage electrosprayed the eluting
peptides directly into a Deca-XP ion trap mass spectrometer equipped
with a nano-LC electrospray ionization source (ThermoFinnigan). Full
MS spectra were recorded on the peptides over a 400 to 1,600 m/z range,
followed by three tandem mass (MS/MS) events sequentially generated
FIG. 1. Sequence of Med25 and similarity to yeast Cse2. Multiple sequence alignments were performed using the MACAW program (18).
Panel A, multiple sequence alignment of Med25 from higher eukaryotes. Accession numbers are NP_060489, human (Hs); NP_619616, mouse
(Mm); BU228883, Gallus gallus (Gg); CA346206, Oncorhynchus mykiss (Om); AL650821, Silurana tropicalis (St); BF426635, Xenopus laevis (Xl);
CG5134, Drosophila melanogaster (Dm); AJ285681, Anopheles gambiae (Ag). Panel B, similarity of Med25 to yeast Cse2. Accession numbers for
higher eukaryotic Med25 orthologs are given under panel A. Accession numbers for yeast Cse2 orthologs are YNR010w, S. cerevisiae (Sc);
AL425926, Kluyveromyces lactis (Kl); AL424134, Kluyveromyces marxianus (Km).
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in a data-dependent manner on the first, second, and third most intense
ions selected from the full MS spectrum (at 35% collision energy). Mass
spectrometer scan functions and HPLC solvent gradients were con-
trolled by the Xcalibur data system (ThermoFinnigan). The software
algorithm 2to3 (13) was used to determine charge state and to delete
spectra of poor quality. SEQUEST (14) was used to match MS/MS
spectra to peptides in a data base containing 82,422 human, mouse, and
rat protein sequences downloaded from NCBI on October 23, 2003. The
validity of peptide/spectrum matches was assessed using the SE-
QUEST-defined parameters, cross-correlation score (XCorr) and nor-
malized difference in cross-correlation scores (DeltCn). Spectra/peptide
matches were only retained if they had a DeltCn of at least 0.08 and
minimum XCorr of 1.8 for 1, 2.5 for 2, and 3.5 for 3 spectra. In
addition, the peptides had to be at least 7 amino acids long. DTASelect
(15) was used to select and sort peptide/spectrum matches passing this
criteria set. Peptide hits from multiple runs were compared using
CONTRAST (15).
RESULTS AND DISCUSSION
We previously described partial purification from rat liver
nuclear extracts of a multiprotein Mediator complex exhibiting
an apparent native molecular mass by gel filtration of more
than 1000 kDa (7). Our most highly purified rat Mediator
contained many previously characterized mammalian Media-
tor subunits, as well as a collection of potential Mediator
subunits including the p28b, Surf5, LCMR1, HSPC296, and
mammalian Intersex proteins, which we subsequently demon-
strated are bona fide subunits of the mammalian Mediator
complex (8, 16). Among the collection of additional proteins
present in our most highly purified rat Mediator fractions and
identified by mass spectrometry was a 142-amino acid protein
encoded by the FLJ10193 open reading frame (Fig. 1A). PSI-
BLAST searches of the NCBI protein data base indicates that
the FLJ10193 protein has diverged substantially during evo-
lution, with obvious FLJ10193 orthologs in insects, but not in
more distantly related species such as Caenorhabditis elegans
and yeast. The N-terminal 50 amino acids of FLJ10193 di-
verge significantly even between human and mouse; in con-
trast, the C-terminal80 amino acids is highly conserved from
mammals to insects, suggesting that it may represent the
functional core of the protein.
Multiple sequence alignments of the FLJ10193 protein with
yeast Mediator subunits identified two short regions of
FLJ10193 with some similarity to S. cerevisiae Mediator sub-
unit Cse2 (Fig. 1B), raising the possibility that FLJ10193 and
Cse2 may be related. Notably, like the sequence of the
FLJ10193 protein, the sequence of Cse2 has diverged substan-
tially during evolution, with apparent Cse2 orthologs in yeasts
closely related to S. cerevisiae, but not in more distantly related
yeasts such as Schizosaccharomyces pombe, Candida, and Neu-
rospora. Below we present direct biochemical evidence that the
FLJ10193 protein, which we designate Med25, is a previously
unrecognized subunit of the mammalian Mediator complex
with features similar to those of yeast Mediator subunit Cse2.
To begin to address the possibility that the Med25 protein is
a component of the mammalian Mediator complex, we sought
to identify Med25-associating proteins. To accomplish this, we
took advantage of four HeLa cell lines stably expressing either
human Mediator subunit Nut2 (10), mouse Mediator subunit
LCMR1 (16), human Mediator subunit Intersex (16), or the
mouse Med25 protein, all with N-terminal FLAG epitope tags.
The FLAG-Nut2 expressing cell line has been used extensively
for preparation of the transcriptionally active TRAP/SMCC
Mediator complex (10), and we have previously used HeLa cell
FIG. 2. SDS-PAGE of mammalian Mediator preparations used
in this study. Anti-FLAG agarose immunoaffinity chromatography of
nuclear extracts prepared from equivalent numbers of HeLa cells and
FLAG-Nut2, FLAG-LCMR1, FLAG-Intersex, and FLAG-Med25 ex-
pressing HeLa cells was carried out as described under “Experimental
Procedures.” Aliquots of anti-FLAG agarose eluates were analyzed by
SDS-PAGE in a 4–20% gradient gel, and proteins were visualized by
silver staining. The positions and relative molecular masses in kDa of
protein size standards are indicated at the left of the gel. HeLa, anti-
FLAG agarose eluate from parental HeLa cells; Fl:Nut2, FLAG-Nut2;
Fl:LCMR1, FLAG-LCMR1; Fl:Intersex, FLAG-Intersex; Fl:Med25,
FLAG-Med25.
FIG. 3. The Med25 protein is present in the purified
TRAPSMCC Mediator complex. Anti-FLAG agarose immunoaffin-
ity chromatography of nuclear extracts from HeLa cells or FLAG-Nut2,
FLAG-LCMR1, FLAG-Intersex, and FLAG-Med25 expressing HeLa
cells was carried out as described under “Experimental Procedures.”
Aliquots of anti-FLAG eluates were fractionated by SDS-PAGE electro-
phoresis in 4–20% gradient gels, and proteins were visualized by West-
ern blotting with antibodies recognizing the Mediator subunits indi-
cated in the figure. Western blots were developed using horseradish
peroxidase-labeled secondary antibodies and Super-Signal West Dura
extended duration substrate. The positions and relative molecular
masses in kDa of protein size standards are indicated at the left of the
blots. HeLa, anti-FLAG agarose eluate from parental HeLa cells; Fl:
Nut2, FLAG-Nut2; Fl:LCMR1, FLAG-LCMR1; Fl:Intersex, FLAG-
Intersex; Fl:Med25, FLAG-Med25.
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lines expressing FLAG-tagged mouse LCMR1 and FLAG-
tagged human Intersex as sources for anti-FLAG immunoaf-
finity purification of the mammalian Mediator complex (16).
Nuclear extracts prepared from equivalent numbers of pa-
rental, FLAG-Nut2, FLAG-LCMR1, FLAG-Intersex, and
FLAG-Med25 expressing HeLa cells were subjected to anti-
FLAG agarose chromatography as described previously for pu-
rification of the TRAPSMCC Mediator complex (10). As shown
in the silver-stained SDS-polyacrylamide gel of Fig. 2, anti-
FLAG agarose eluate from FLAG-Med25 expressing HeLa cells
appeared to include a very similar set of proteins as the
TRAPSMCC Mediator complex purified from FLAG-Nut2,
FLAG-LCMR1, or FLAG-hIntersex expressing HeLa cells. In
addition, analysis of Med25-associating proteins present in the
anti-FLAG agarose eluate from FLAG-Med25 expressing HeLa
cells by tandem mass spectrometry (Table I in Supplemental
Material) and by Western blotting (Fig. 3) identified nearly all
of the mammalian Mediator subunits known to be present in
the TRAPSMCC Mediator complex, arguing that Med25 is a
previously unrecognized subunit of the mammalian Mediator
complex. The Med25 protein was detected by Western blotting
only in anti-FLAG agarose eluates from FLAG-Med25 and
FLAG-Intersex expressing HeLa cells. Med25 was, however,
detected by tandem mass spectrometry in anti-FLAG-agarose
eluates from all four HeLa stable cell lines, but not from pa-
rental HeLa cells (Table II in Supplemental Material). These
observations suggest that the Med25 protein is present at
varying levels in these different Mediator preparations. Fi-
nally, and consistent with previous findings indicating that the
mammalian Mediator complex binds to and can be purified
through interactions with the VP16 transcriptional activation
domain (4, 10), we observe that the Med25 protein can be
purified together with other Mediator subunits from nuclear
extracts of FLAG-Med25 expressing HeLa cells by GST-VP16
chromatography. As shown in the Western blot of Fig. 4, the
Med25 protein and representative Mediator subunits Cdk8,
Med8, Med6, and TRAP36 are copurified from HeLa cell nu-
clear extracts using immobilized GST-VP16, but not GST.
Thus, the Med25 protein copurifies with the mammalian Me-
diator complex by several independent methods, arguing that it
is a bona fide Mediator subunit.
To obtain additional evidence supporting assignment of the
Med25 protein as a new subunit of the mammalian Mediator
complex, we sought to identify pair-wise binding partners of
Med25 among the known mammalian Mediator subunits. To
accomplish this, we began by exploiting a convenient screen (8)
FIG. 4. The Med25 protein associates with the VP16 transcrip-
tional activation domains. GST-VP16 or GST alone was prebound to
glutathione-Sepharose 4B beads in 10 mM Hepes-NaOH (pH 7.9), 0.3 M
KCl, 1.5 mM MgCl2, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride,
and 0.1% Triton X-100 and incubated for at least 4 h at 4 °C with
undialyzed nuclear extracts prepared from FLAG-Med25 expressing
HeLa cells according to the method of Dignam et al. (11). The glutathi-
one-Sepharose beads were then washed 7 times with a 50-fold excess of
the same buffer containing 0.5 M KCl, and bound proteins were eluted
from the beads with 100 mM Tris-HCl (pH 7.9), 0.12 M NaCl, 0.1%
Triton X-100, and 20 mM glutathione. Aliquots of glutathione-Sepha-
rose eluates were analyzed by 10% or 13% SDS-PAGE, and proteins
were visualized by Western blotting with antibodies recognizing the
Mediator subunits indicated in the figure. Western blots were devel-
oped using horseradish peroxidase-labeled secondary antibodies and
Super-Signal West Dura extended duration substrate or SuperSignal
West Femto Maximum Sensitivity Substrate.
FIG. 5. Screening for Med25 binding partners among the known mammalian mediator subunits. 35S-labeled Mediator subunits were
synthesized in the rabbit reticulocyte lysate TNT T7 Quick Coupled Transcription/Translation System (Promega) programmed with pcDNA3.1
expression vectors encoding the mammalian Mediator subunits and other proteins indicated in the figure. Reticulocyte lysates containing the
indicated 35S-labeled proteins were mixed with bacterially expressed and purified GST-Med25 or GST alone prebound to glutathione-Sepharose
4 Fast Flow beads in phosphate-buffered saline and incubated for 2 h with rocking at 4 °C. The beads were washed 2 times with 40 mM Tris-HCl
(pH 7.5), 0.25 M NaCl, and 0.2% Triton X-100. The beads were then washed once with Tris-buffered saline, and proteins were eluted from the beads
with Tris-buffered saline containing 10 mM glutathione. Aliquots of glutathione-Sepharose eluates were fractionated by 12% SDS-PAGE, and
proteins were visualized using a Typhoon 8600 PhosphorImager (Amersham Biosciences).
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to assess the ability of Med25 to interact with known mamma-
lian Mediator subunits prepared by in vitro translation in
rabbit reticulocyte lysates. pcDNA3.1 expression vectors encod-
ing the known mammalian Mediator subunits and additional
proteins indicated in Fig. 5 were used to program rabbit reticu-
locyte lysates for translation of 35S-labeled Mediator proteins.
Binding of 35S-labeled Mediator proteins to a GST-Med25 fu-
sion protein was assayed in GST pull-down experiments using
glutathione-agarose beads, and bound proteins were visualized
by autoradiography. The results of this screen revealed signif-
icant and reproducible binding of Med25 to Mediator subunit
TRAP36 (Fig. 5), the mammalian ortholog of yeast Mediator
subunit Med4. Notably, in a previous study, S. cerevisiae Me-
diator subunit Cse2 was found to interact directly only with
yeast Mediator subunit Med4 (17), suggesting that Med25 and
Cse2 may be functionally related.
To confirm and extend this finding, we sought to reconstitute
the Med25-TRAP36 interaction detected in in vitro translation
experiments in transiently transfected human 293T cells and
with recombinant proteins expressed in Sf21 insect cells and E.
coli. As shown in Fig. 6A, the TRAP36 protein could be coim-
munoprecipitated with the Med25 protein from lysates of 293T
cells cotransfected with pcDNA3.1 expression vectors encoding
TRAP36 and Med25. In addition, direct pairwise binding of
Med25 to TRAP36 was detected following their coexpression in
Sf21 cells (Fig. 6B) and in E. coli (Fig. 6C), arguing that Med25
binds directly to TRAP36 and may be recruited to the Mediator
complex through this interaction.
In summary, in this report we identify the previously un-
characterized FLJ10193 protein as a new mammalian Media-
tor subunit designated Med25. Although lower eukaryotic or-
thologs of the Med25 protein have not yet been unequivocally
identified, our findings have brought to light structural and
functional similarities between Med25 and yeast Mediator sub-
unit Cse2. First, Med25 exhibits limited sequence similarity
with Cse2. Second, like Cse2, the Med25 protein forms a het-
erodimer with Mediator subunit Med4 (or TRAP36 in mam-
mals) and thus may be recruited to the “middle module” of the
mammalian Mediator complex through its interaction with
Med4. Whether Med25 fulfills a similar role as Cse2 in Medi-
ator, however, remains to be determined.
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